Static Lung Hyperinflation and Sympathetic Nerve Activity-Associated Large Artery Stiffness in COPD Patients
Phase of Trial: Phase IV
Latest Information Update: 22 Aug 2019
Price : $35 *
At a glance
- Drugs Umeclidinium/vilanterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 20 Aug 2019 Planned End Date changed from 30 Dec 2019 to 30 May 2020.
- 20 Aug 2019 Planned primary completion date changed from 1 Aug 2019 to 1 Apr 2020.
- 25 Jan 2019 Status changed from not yet recruiting to recruiting.